Dr. Sayeeda Sultana, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5060 Rosemead Blvd, Pico, CA 90660 Phone: 562-942-9895 Fax: 562-222-2225 |
News Archive
An international team of investigators based in the United States and Germany has modified the nanoscale printing technique known as dip-pen nanolithography to create large numbers of model cell membranes.
BioSante Pharmaceuticals, Inc. today announced positive GVAX AML Vaccine results and BioSante's receipt of Orphan Drug designation from the FDA's Office of Orphan Products Development for GVAX AML Vaccine in the treatment of acute myeloid leukemia. This Orphan Drug designation is the second GVAX cancer vaccine from BioSante to secure FDA orphan drug designation.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary SpiegelmerĀ® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with SpiegelmerĀ® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
University of Michigan scientists report highly encouraging evidence that a super-fine oil-and-water emulsion, already shown to kill many other microbes, may be able to quell the ravaging, often drug-resistant infections that cause nearly all cystic fibrosis deaths.
› Verified 7 days ago